Drug-device maker Kaléo has secured a federal contract worth $96.1 million, enlisting in an effort to bolster U.S. biodefense ...

Kaléo, a Glen Allen, Virginia-based drug-delivery device and auto-injector company, announced on October 7, 2026 that it has ...

Phillips-Medisize, in collaboration with its customer, Ascendis Pharma, was recently recognized with a third industry award for the Skytrofa Auto-Injector. The Red Dot Award recognizes the drug ...

Autoinjector concept, developed in collaboration with Sagentia Medical, aims to help ensure life-saving epinephrine is always within reach. BOSTON & CAMBRIDGE, England, August 26, 2026--(BUSINESS WIRE ...

Kaléo, a global leader in drug-delivery device technology and auto-injector innovation, today announced it has been awarded a Project BioShield contract by the Biomedical Advanced Research and ...